Health-related quality of life impact in a randomised phase III study of the combination of dabrafenib and trametinib versus dabrafenib monotherapy in patients with BRAF V600 metastatic melanoma-Reference-Cited by-同舟云学术

Health-related quality of life impact in a randomised phase III study of the combination of dabrafenib and trametinib versus dabrafenib monotherapy in patients with BRAF V600 metastatic melanoma

Published:2015-05 Issue:7 Volume:51 Page:833-840
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Schadendorf Dirk^ORCID,Amonkar Mayur M.,Stroyakovskiy Daniil,Levchenko Evgeny,Gogas Helen,de Braud Filippo,Grob Jean-Jacques,Bondarenko Igor,Garbe Claus,Lebbe Celeste,Larkin James,Chiarion-Sileni Vanna,Millward Michael,Arance Ana,Mandalà Mario,Flaherty Keith T.,Nathan Paul,Ribas Antoni,Robert Caroline,Casey Michelle,DeMarini Douglas J.,Irani Jhangir G.,Aktan Gursel,Long Georgina V.

Funder

GlaxoSmithKline

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference26 articles.

1. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010

2. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma;Robert;N Engl J Med,2011

3. Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial;Robert;Lancet,2014

4. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N Engl J Med,2011

5. Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial;Hauschild;Lancet,2012

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System Events for Trametinib;Cureus;2024-08-27

2. Cutaneous Melanoma: An Overview of Physiological and Therapeutic Aspects and Biotechnological Use of Serine Protease Inhibitors;Molecules;2024-08-16

3. Systemic Treatment of Melanoma;Rook's Textbook of Dermatology;2024-03-19

4. Radiation-induced cognitive toxicity in era of precision oncology – from pathophysiology to strategies for limiting toxicities;Česká a slovenská neurologie a neurochirurgie;2023-10-31

5. Revisiting the Role of B-RAF Kinase as a Therapeutic Target in Melanoma;Current Medicinal Chemistry;2023-10-19